AAV Integration Site Analysis is a technical service that utilizes high-throughput sequencing (NGS) and bioinformatics analysis to comprehensively and accurately identify the insertion location and frequency of the AAV vector genome within the host cell chromosome, as well as its surrounding genomic context. Its core purpose is to assess the integration potential and potential genotoxicity risks of AAV vectors in gene therapy products, providing critical safety data for preclinical and clinical trials.

Exogenous gene Integration Site Analysis uses molecular biology techniques to precisely identify the insertion location, copy number, and integration status of an exogenous gene within the host cell genome. This test not only examines whether the exogenous gene has successfully integrated, but also focuses on analyzing the characteristics of the integration site, such as whether it is located in the gene coding region, regulatory region, or repetitive sequence, thereby assessing its potential impact on host gene function.

Material Number: CBP10402

Material Number: CBP10428

Material Number: CBP10402